pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 17·1 min read
save

Cyber extortion group claims to have stolen over a terabyte of Novo Nordisk data after failed $25 million ransom demand

Jun 17, 2026·read at STAT ↗Negative

A cyber‑extortion group called FulcrumSec said it obtained more than one terabyte of data from Novo Nordisk.

The group said it tried to extract a $25 million ransom, but Novo Nordisk did not pay, and the attackers are now considering selling portions of the stolen information.

The claim was reported by Reuters and highlights growing cyber‑security risks for large pharmaceutical companies that handle sensitive patient and research data.

In a separate regulatory note, the FDA issued 25 warning letters to telehealth firms for making unsubstantiated claims about compounded GLP‑1 drugs, underscoring heightened scrutiny in the sector.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Pharmalittle: We’re reading about hackers extorting Novo, an FDA about-face, and more”

read at STAT ↗
660 words · retrieved Jun 17
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
NOVO7Novo Nordisk Inc5PATHPFIZERSanofi
drugs
Obesity
topics
ApprovalObesityType 2 Diabetes

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Jul 20Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independenceBioSpace
  • Jun 16STAT+: Pharmalittle: We’re reading about Medicare and obesity drugs, Germany’s pricing plans, and moreSTAT
  • Aug 19Novo takes first round of oral obesity duel. Can it stay ahead of Lilly?BioSpace
  • Aug 5Novo CEO accepts ‘couple of setbacks’ in R&D as CagriSema posts more mixed dataFierce Biotech